A Systematic Review of Clinical Trials on the Efficacy and Safety of CRLX101 Cyclodextrin-Based Nanomedicine for Cancer Treatment

CRLX101 is a cyclodextrin-based nanopharmaceutical designed to improve the delivery and efficacy of the anti-cancer drug camptothecin. Cyclodextrins have unique properties that can enhance drug solubility, stability, and bioavailability, making them an attractive option for drug delivery. The use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Serrano-Martínez, Ana, Victoria-Montesinos, Desirée, García-Muñoz, Ana María, Hernández-Sánchez, Pilar, Lucas-Abellán, Carmen, González-Louzao, Rebeca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383811/
https://www.ncbi.nlm.nih.gov/pubmed/37514011
http://dx.doi.org/10.3390/pharmaceutics15071824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383811/
https://www.ncbi.nlm.nih.gov/pubmed/37514011
http://dx.doi.org/10.3390/pharmaceutics15071824

Ejemplares similares